B

Bright Minds Biosciences Inc
CNSX:DRUG

Watchlist Manager
Bright Minds Biosciences Inc
CNSX:DRUG
Watchlist
Price: 58.27 CAD -1.24%
Market Cap: 260.1m CAD
Have any thoughts about
Bright Minds Biosciences Inc?
Write Note

Bright Minds Biosciences Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bright Minds Biosciences Inc
Interest Income Expense Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
B
Bright Minds Biosciences Inc
CNSX:DRUG
Interest Income Expense
-CA$5.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Interest Income Expense
-$10.1m
CAGR 3-Years
-19%
CAGR 5-Years
-21%
CAGR 10-Years
-52%
Repare Therapeutics Inc
NASDAQ:RPTX
Interest Income Expense
$13.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Interest Income Expense
$12.6m
CAGR 3-Years
182%
CAGR 5-Years
7%
CAGR 10-Years
21%
Covalon Technologies Ltd
XTSX:COV
Interest Income Expense
-CA$56.9k
CAGR 3-Years
58%
CAGR 5-Years
27%
CAGR 10-Years
1%
Spectral Medical Inc
TSX:EDT
Interest Income Expense
-CA$11m
CAGR 3-Years
-281%
CAGR 5-Years
-226%
CAGR 10-Years
-101%

See Also

What is Bright Minds Biosciences Inc's Interest Income Expense?
Interest Income Expense
-5.6k CAD

Based on the financial report for Sep 30, 2023, Bright Minds Biosciences Inc's Interest Income Expense amounts to -5.6k CAD.

Back to Top